newsfilter
← Latest News
GlobeNewswire·

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ:DMK) ("DMK"), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment